Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer
Clinical trial NCT01646684 · COMPLETED
Trial details
- NCT number
- NCT01646684
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-08
- Primary completion
- 2018-11-13
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.